Equity Analysis /
United States of America

US : Teva Pharmaceutical Industries Ltd. - TEVA | After a Losing Year for Generic Approvals, Teva Closes Out 2021 With Gx Narcan Launch

    Michael Parolari
    Michael Parolari

    Research Associate

    CGS-CIMB
    23 December 2021
    Published by